glp-1 drugs insurance coverage How many adults with private health could use GLP-1 medications are transforming medical

doi: 10.1023/A:1010635131228 [DOI] [PubMed] [Google Scholar] 185

Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes

Each question is a 7-item Likert scale ranging from strongly disagree to strongly agree. Craving score was calculated by averaging each items rating, with higher scores indicating greater craving

However, it has not achieved the same level of success as stand-alone GLP-1 receptor agonists like semaglutide and dulaglutide

Supplementary information Source data Source Data Fig

When these fundamentals are present, you avoid guesswork and focus on the fun